David Levitz, PhD, is the founder and Chief Technology Officer of MobileODT. In addition to his roles at MobileODT, Dr. Levitz also chairs the "Optics and Biophotonics in Low Resource Settings" conference at SPIE's annual Photonics West meetings. Dr. Levitz got a Bachelor’s degree in biomedical engineering/optics from the University of Rochester (Rochester, NY, USA) in 2002. He then spent 3 years working with Risø National Laboratory (Roskilde, Denmark), and Lund University (Lund, Sweden) developing an image-processing algorithm to measure optical scattering properties from optical coherence tomography (OCT) images. Using this method, Dr. Levitz identified differences between normal and atherosclerotic arterial tissues. Dr. Levitz’s Master’s project was accepted into “Optics in 2004” issue of Optics and Photonics News, highlighting a key contribution to the field of biomedical optics that year. Following his years in Scandinavia, Dr. Levitz joined a leading research group in biomedical optics at Oregon Health & Science University, where he refined the method developed in earlier work and found a relationship between enzymatic matrix remodeling in collagen gels and its scattering properties, which could be measured non-invasively. Dr. Levitz was awarded a Whitaker scholarship for a postdoctoral fellowship in Israel.